All Stories

  1. Gynäkologische Endokrinologie
  2. Hormontherapie
  3. Knochenstoffwechsel
  4. Lack of evidence that progesterone in ovulatory cycles causes breast cancer
  5. Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers
  6. Cost-effectiveness of opportunistic QCT-based osteoporosis screening for the prediction of incident vertebral fractures
  7. Correction: Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) – Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Manageme...
  8. Correction: Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondar...
  9. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, September 2022) – Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and on the Management of Preter...
  10. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention...
  11. Phytotherapie bei klimakterischen Beschwerden
  12. Reproductive endocrinology characteristics in young women with osteoporosis
  13. Perimenopausal Bone Loss Is Associated with Ovulatory Activity—Results of the PeKnO Study (Perimenopausal Bone Density and Ovulation)
  14. Knochengesundheit und Hochleistungssport
  15. Bone metabolism in PCOS – influence of progestins
  16. Eignet sich die HRT zur Primärprävention?
  17. Opportunistic QCT Bone Mineral Density Measurements Predicting Osteoporotic Fractures: A Use Case in a Prospective Clinical Cohort
  18. Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) – Part 1, Basic Assessment of the Woman
  19. Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) – Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease
  20. Prävention und Therapie der Frühgeburt. Leitlinie der DGGG, OEGGG und SGGG (S2k-Niveau, AWMF-Registernummer 015/025, Februar 2019) – Teil 2 mit Empfehlungen zur tertiären Prävention der Frühgeburt und zum Management des frühen vorzeitigen Blasensprungs
  21. Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
  22. Laboranalytik bei primärer und sekundärer Amenorrhö
  23. Prävention und Therapie der Frühgeburt. Leitlinie der DGGG, OEGGG und SGGG (S2k-Niveau, AWMF-Registernummer 015/025, Februar 2019) – Teil 1 mit Empfehlungen zur Epidemiologie, Ätiologie, Prädiktion, primären und sekundären Prävention der Frühgeburt
  24. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) – Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm...
  25. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015/025, February 2019) – Part 2 with Recommendations on the Tertiary Prevention of Preterm Birth and the Management of Preterm Premature Ru...
  26. Hormontherapie in der Peri- und Postmenopause
  27. Integrated morphologic and molecular analysis of Trichomonas vaginalis, Mycoplasma hominis, and human papillomavirus using cytologic smear preparations
  28. POCT in obstetrics and gynecology
  29. The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study
  30. Hormonal Smartphone Diagnostics
  31. Mammographic Density and Vitamin D Levels – A Cross-sectional Study
  32. C-Peptide, Baseline and Postprandial Insulin Resistance after a Carbohydrate-Rich Test Meal – Evidence for an Increased Insulin Clearance in PCOS Patients?
  33. POCT in Gynäkologie und Geburtshilfe
  34. Premenopausal Trabecular Bone Loss is Associated with a Family History of Fragility Fracture
  35. Vitamin D and Mammographic Findings
  36. Osteoporose – Prävention: warum und wie?
  37. Non-reproductive Effects of Anovulation
  38. Do Pregnancy and Parenthood Affect the Course of PCO Syndrome? Initial Results from the LIPCOS Study (Lifestyle Intervention for Patients with Polycystic Ovary Syndrome [PCOS])
  39. The biomarker sex hormone-binding globulin – From established applications to emerging trends in clinical medicine
  40. MR-based trabecular bone microstructure is not altered in subjects with indolent systemic mastocytosis
  41. Important aspects in diagnosing adenomyosis
  42. Pille und Krebsrisiko
  43. Translational Risk Models
  44. Risk Reduction of Cervical Cancer Through HPV Screening and Vaccination—Assumptions and Reality
  45. Fractures due to transient osteoporosis of pregnancy
  46. Health technology assessment of utilization, practice and ethical issues of self-pay services in the German ambulatory health care setting
  47. Endokrinologie. Klimawandel - Wenn Frauen in die Wechseljahre kommen
  48. Counseling reproductive health issues in women with congenital heart disease
  49. Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years
  50. Progesterone and bone: a closer link than previously realized
  51. 104 FSH AND PERIMENOPAUSAL BONE DENSITY
  52. Progesteron und Knochen
  53. Breast cancer after hormone replacement therapy – does prognosis differ in perimenopausal and postmenopausal women?
  54. Reproduktionsmedizin. Assistierte Reproduktion und Knochen
  55. Contraception in Women With Congenital Heart Disease
  56. Sexuality and Reproductive Health in Women With Congenital Heart Disease
  57. Progesterone and Bone: Actions Promoting Bone Health in Women
  58. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
  59. Laboratoriumsmedizinische Strategien in der endokrinologischen Diagnostik ovarieller Störungen
  60. Ovulationsgeschehen und Knochenmetabolismus
  61. In reply:
  62. Letter to the Editor
  63. Influence of pattern of menopausal transition on the amount of trabecular bone loss
  64. The 3D-based scaling index algorithm: a new structure measure to analyze trabecular bone architecture in high-resolution MR images in vivo
  65. Unsuccessful attempt to demonstrate progesterone's bone formation actions
  66. Knochenstoffwechsel, Knochendichte und Östrogenspiegel in der Perimenopause: eine prospektive 2-Jahres-Untersuchung
  67. Hormontherapie um die Menopause
  68. Bone metabolism during the perimenopausal transition: a prospective study
  69. Changes of Biochemical Bone Markers during the Menopausal Transition
  70. Kontrazeption bei Patientinnen mit angeborenen Herzfehlern
  71. Gender differences in myocardial blood flow dynamics
  72. Idiopathische Subfertilität: Schwangerschaftsraten nach IVF-Behandlung im minimal stimulierten monofollikulären Ovarialzyklus
  73. A three step protocol for the treatment of idiopathic subfertility
  74. Gynäkologische Endokrinologie
  75. Schwangerschaft bei angeborenen Herzfehlern